Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01922895 · ClinicalTrials.gov registry record · NA
Novel Therapies in Moderately Severe Acute Alcoholic Hepatitis
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT01922895 is a NA study that was terminated before completion, run by University of Texas Southwestern Medical Center. The registered enrollment target is 45 participants.
The verdict
NCT01922895, a NA study, was terminated before completion, sponsored by University of Texas Southwestern Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This study is being done to find out whether a diet supplemented with a probiotic nutrient can improve alcoholic hepatitis and gut complications compared to routine standard care.
Interventions
- DIETARY_SUPPLEMENT Lactobacillus Rhamnosus GG
- DRUG Placebo for Probiotic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2013-08-01 |
| Est. Completion | 2021-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01922895
The ClinicalTrials.gov registry entry for NCT01922895 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lactobacillus Rhamnosus GG is the first listed.
NCT01922895 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01922895 about?
NCT01922895 is a clinical study titled "Novel Therapies in Moderately Severe Acute Alcoholic Hepatitis". This study is being done to find out whether a diet supplemented with a probiotic nutrient can improve alcoholic hepatitis and gut complications compared to routine standard care.
What is the current status of trial NCT01922895?
This trial is currently terminated. It is a NA study. The enrollment target is 45 participants. The study started on 2013-08-01. Estimated completion is 2021-08-31.
What interventions are being tested in trial NCT01922895?
The interventions under investigation include: Lactobacillus Rhamnosus GG (DIETARY_SUPPLEMENT), Placebo for Probiotic (DRUG).
Who is sponsoring clinical trial NCT01922895?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.